Featured Research

from universities, journals, and other organizations

Change in mammography guidelines questioned

Date:
January 29, 2010
Source:
SAGE Publications
Summary:
The methodology and evidence behind a widely publicized change in national mammography guidelines is questionable, according to a new review.

Los Angeles, London, New Delhi, Singapore and Washington DC (Jan 28 2010) The methodology and evidence behind a widely publicized change in national mammography guidelines is questionable, according to a review in the Journal of Diagnostic Medical Sonography (JDMS).

In November 2009, the US Preventive Services Task Force (USPSTF) published a report in the Annals of Internal Medicine discussing the screening techniques for the early detection of breast cancer. A few isolated portions of that report, regarding recommended changes for the use of mammography, were widely discussed in the media, and garnered tremendous public attention.

This new JDMS article provides an evidenced-based review of the work and recommendations contained in the USPSTF report and raises the question whether the controversial conclusions for breast cancer screening were supported by established scientific measurement and research standards. The JDMS review found low methodological scores in the USPSTF report, which may place in question the recommendations generated from the report.

The article concludes that, despite the report's depiction as a systematic review, the USPSTF report was actually just a review of literature, which reduces the overall scientific impact of the report to a much lower level in the hierarchy of evidence.

"Even though the methodology used by the USPSTF is not clear and the level of evidence is questionable, the proposed recommendations have been highly publicized." writes author Kevin D. Evans. "The most appropriate way to guarantee patients are receiving quality health care is to become adept at reviewing published research and implementing information that will change current practice patterns."


Story Source:

The above story is based on materials provided by SAGE Publications. Note: Materials may be edited for content and length.


Journal Reference:

  1. Evans et al. Review of the US Preventive Services Task Force's Statement on Screening for Breast Cancer. Journal of Diagnostic Medical Sonography, 2010; 26 (1): 19 DOI: 10.1177/8756479309359170

Cite This Page:

SAGE Publications. "Change in mammography guidelines questioned." ScienceDaily. ScienceDaily, 29 January 2010. <www.sciencedaily.com/releases/2010/01/100128171820.htm>.
SAGE Publications. (2010, January 29). Change in mammography guidelines questioned. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/01/100128171820.htm
SAGE Publications. "Change in mammography guidelines questioned." ScienceDaily. www.sciencedaily.com/releases/2010/01/100128171820.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins